InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by COHEN RON, Chief Executive Officer. Director active across 3 companies, notably Acorda Therapeutics INC. Aggregated, 11 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €9k. History available since 3 September 2021. The latest transaction was disclosed on 16 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
10,156 shares@ US$0.60100.0% of flowCommon StockSEC:0001209191-23-020044:0
Ideal exit: 11 Dec 2023 (T+270)
2,289 shares@ US$1.701410.8% of flowCommon StockSEC:0001209191-22-020260:0
3,940 shares@ US$4.3844.6% of flowCommon StockSEC:0001209191-21-055099:0
3,940 shares@ US$4.3844.6% of flowCommon StockSEC:0001209191-21-055099
14,642 sharesCommon StockSEC:0001209191-16-095987:0
4,005 sharesCommon StockSEC:0001209191-16-095987:1
10,591 sharesCommon StockSEC:0001209191-16-095987:2
11 of 11 declarations
About COHEN RON
Ron Cohen is the President and CEO of ACORDA THERAPEUTICS INC. He leads the company by overseeing all operations and defining the overall strategy. His role is essential in ensuring the company's growth and innovation in the biotechnology sector. Through his leadership, he guides the team toward achieving business objectives while ensuring regulatory compliance and stakeholder satisfaction.
